Tashir Medica

Investor type

CVC / VC / PE

Founded

2015

AUM

-

Location

Moscow, Moscow, Russia

Investment Ticket

$10-50 m

Investment Stage

Seed Series B Late Stage (Series C+) Series A

Region of investment

Europe Asia

ESG Focus

Impact investor
Investor profile last updated: 21 August, 2026

Profile

Tashir Medica is a vertically integrated investment holding company based in Moscow, Russia, founded in 2015. It was established as a joint venture between MEDANKO, a leading distributor of medical diagnostic equipment in Russia, and Tashir Group, a diversified industrial and construction group. The firm is led by key figures such as Arsen Galstyan and Nikolai Shum, and employs over 800 people. Tashir Medica distinguishes itself through its strategic management of portfolio companies and its focus on medical projects.

The firm invests in sectors including medical services, EPCM, medical equipment, distribution, digital health, biotechnology, and pharmaceuticals. Tashir Medica typically invests in Series B rounds, primarily focusing on Russian startups. The firm is open to both strategic and financial partnerships, integrating portfolio companies into its ecosystem. It has a portfolio of over 15 companies, emphasizing innovation, digitalization, and new business models.

Notable investments by Tashir Medica include Botkin.AI - a healthtech company, and UNIM - a life sciences firm. These investments reflect the firm's deep involvement in the healthcare and technology sectors, with a particular emphasis on digital health and life sciences.

Industry

Biotechnology Healthcare Services Medical Devices Pharmaceuticals MedTech Life Sciences HealthTech

Contacts

Name
Title
Email
avatar
Arsen Galstyan Managing partner
Managing partner
a•••@•••
avatar
Yaroslav Markov Managing Director
Managing Director
y•••@•••
Upgrade to see contacts
avatar
97PqfglMm2OFN8IL 97PqfglMm2OFN8IL
97PqfglMm2OFN8IL
avatar
97PqfglMm2OFN8IL 97PqfglMm2OFN8IL
97PqfglMm2OFN8IL
avatar
97PqfglMm2OFN8IL 97PqfglMm2OFN8IL
97PqfglMm2OFN8IL
Investment-team contacts for Tashir Medica — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Tashir Medica

Tashir Medica is a venture capital and private equity firm that also operates as a corporate VC (CVC). It backs companies at Seed, Series B, Late Stage (Series C+) and Series A, writing tickets of $10-50 m.
Tashir Medica is located in Moscow, Moscow, Russia.
Tashir Medica was founded in 2015.
Tashir Medica invests in companies and startups in Biotechnology, Healthcare Services, Medical Devices, Pharmaceuticals, MedTech, Life Sciences, HealthTech.
Tashir Medica invests in companies and startups in Europe, Asia.
Tashir Medica invests in companies and startups at Seed, Series B, Late Stage (Series C+), Series A.
Tashir Medica usually invests $10-50 m on average.
Yes, Tashir Medica is impact investor.
Tashir Medica can be reached through its website tashir-medica.com. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Tashir Medica — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Tashir Medica directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 21 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.